Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2.

MLA

Halliday, Alice, et al. “Development and Evaluation of Low-Volume Tests to Detect and Characterize Antibodies to SARS-CoV-2.” Frontiers in Immunology, vol. 13, Nov. 2022, pp. 01-20. EBSCOhost, https://doi.org/10.3389/fimmu.2022.968317.

APA

Halliday, A., Long, A. E., Baum, H. E., Thomas, A. C., Shelley, K. L., Oliver, E., Gupta, K., Francis, O., Kavanagh Williamson, M., Di Bartolo, N., Randell, M. J., Ben-Khoud, Y., Kelland, I., Mortimer, G., Ball, O., Plumptre, C., Chandler, K., Obst, U., Secchi, M., & Piemonti, L. (2022). Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2. Frontiers in Immunology, 13, 01-20. https://doi.org/10.3389/fimmu.2022.968317

Chicago

Halliday, Alice, Anna E. Long, Holly E. Baum, Amy C. Thomas, Kathryn L. Shelley, Elizabeth Oliver, Kapil Gupta, et al. 2022. “Development and Evaluation of Low-Volume Tests to Detect and Characterize Antibodies to SARS-CoV-2.” Frontiers in Immunology 13 (November): 01-20. doi:10.3389/fimmu.2022.968317.